The American Diabetes Association (ADA) has introduced new care guidelines for diabetes, focusing on better treatment and prevention. One key update is the recommendation to monitor vitamin B12 levels in people taking metformin, a common diabetes medication.
The guidelines also highlight the use of GLP-1 receptor agonists — medications that help with weight loss — to treat people with both diabetes and obesity or liver problems. This means more effective treatment for people dealing with multiple health issues.
There’s also hope for those at risk of Type 1 diabetes. A new drug called teplizumab could delay the onset of the disease, offering people more time to prepare and manage their health. These updates show a shift toward more personalized and proactive care for diabetes patients.
